Okobi, O. E., Udoete, I. O., Fasehun, O. O., Okobi, T., Evbayekha, E. O., Ekabua, J. J., Elukeme, H., Ebong, I. L., Ajayi, O. O., Olateju, I. V., Taiwo, A., Anaya, I. C., Omole, J. A., Nkongho, M. B., Ojinnaka, U., Ajibowo, A. O., Ogbeifun, O. E., Ugbo, O. O., Okorare, O., Akinsola, Z., Olusoji, R. A., Amanze, I. O., Nwafor, J. N., Ukoha, N. A., & Elimihele, T. A. (2021). A review of four practice guidelines of inflammatory bowel disease. Cureus, 13(8), e16859.

PubMed  PubMed Central  Google Scholar 

Feuerstein, J. D., Moss, A. C. & Farraye, F. A. (2019). Ulcerative colitis. Mayo Clinic Proceedings, 94(7), 1357–1373.

Article  PubMed  Google Scholar 

Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J. F. (2017). Ulcerative colitis. Lancet, 389(10080), 1756–1770.

Article  PubMed  Google Scholar 

Wu, M., Li, P., An, Y., Ren, J., Yan, D., Cui, J., Li, D., Li, M., Wang, M. & Zhong, G. (2019). Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacological Research, 150, 104489.

Article  CAS  PubMed  Google Scholar 

Engel, F., Berens, S., Gauss, A., Schaefert, R., Eich, W. & Tesarz, J. (2021). Higher levels of psychological burden and alterations in personality functioning in Crohn’s Disease and ulcerative colitis. Frontiers in Psychology, 12, 671493.

Article  PubMed  PubMed Central  Google Scholar 

Wei, S. C., Sollano, J., Hui, Y. T., Yu, W., Santos Estrella, P. V., Llamado, L. J. Q. & Koram, N. (2021). Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology, 15(3), 275–289.

Article  CAS  Google Scholar 

Kawalec, P.(2016). Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review. Archives of Medical Science, 12(2), 295–302.

Article  PubMed  PubMed Central  Google Scholar 

Sehgal, P., Colombel, J. F., Aboubakr, A., & Narula, N. (2018). Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Ther, 47(12), 1597–1609.

Article  CAS  PubMed  Google Scholar 

Tsusaka, T., Makino, B., Ohsawa, R., & Ezura, H. (2020). Evaluation of heritability of β-eudesmol/hinesol content ratio in Atractylodes lancea De Candolle. Hereditas, 157(1), 020–00123.

Article  Google Scholar 

Han, J., Zhu, X., Gao, Z., Xiao, Y., Zhang, J., Wang, P., Fang, J., Li, Y., Zhu, Y., Jin, N., Lu, H., Lin, D. & Liu, W. (2023). Antiviral effects of Atractyloside A on the influenza B virus (Victoria strain) infection. Frontiers in Microbiology, 13, 1067725.

Article  PubMed  PubMed Central  Google Scholar 

Hossen, M. J., Amin, A., Fu, X. Q., Chou, J. Y., Wu, J. Y., Wang, X. Q., Chen, Y. J., Wu, Y., Li, J., Yin, C. L., Liang, C., Chou, G. X. & Yu, Z. L. (2021). The anti-inflammatory effects of an ethanolic extract of the rhizome of Atractylodes lancea, involves Akt/NF-κB signaling pathway inhibition. Journal of Ethnopharmacology, 277, 114183.

Article  CAS  PubMed  Google Scholar 

Wu, J., Xu, R., Lu, J., Liu, W., Yu, H., Liu, M., Li, J., Yin, M., Peng, H., & Zha, L. (2021). Molecular cloning and functional characterization of two squalene synthase genes in Atractylodes lancea. Planta, 255(1), 021–03797.

Google Scholar 

Masuda, Y., Kadokura, T., Ishii, M., Takada, K. & Kitajima, J. (2015). Hinesol, a compound isolated from the essential oils of Atractylodes lancea rhizome, inhibits cell growth and induces apoptosis in human leukemia HL-60 cells. Journal of Natural Medicines, 69(3), 332–339.

Article  CAS  PubMed  Google Scholar 

Guo, W., Liu, S., Ju, X., Du, J., Xu, B., Yuan, H., Qin, F. & Li, L. (2019). The antitumor effect of hinesol, extract from Atractylodes lancea (Thunb.) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF-κB pathway in non-small cell lung cancer cell lines A549 and NCI-H1299. Journal of Cellular Biochemistry, 120(11), 18600–18607.

Article  CAS  PubMed  Google Scholar 

Satoh, K., Nagai, F. & Kano, I. (2000). Inhibition of H+,K+ -ATPase by hinesol, a major component of So-jutsu, by interaction with enzyme in the E1 state. Biochemical Pharmacology, 59(7), 881–886.

Article  CAS  PubMed  Google Scholar 

Dai, Y., Lu, Q., Li, P., Zhu, J., Jiang, J., Zhao, T., Hu, Y., Ding, K. & Zhao, M. (2023). Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology, 300, 115690.

Article  CAS  PubMed  Google Scholar 

Yan, Y. X., Shao, M. J., Qi, Q., Xu, Y. S., Yang, X. Q., Zhu, F. H., He, S. J., He, P. L., Feng, C. L., Wu, Y. W., Li, H., Tang, W. & Zuo, J. P. (2018). Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacologica Sinica, 39(10), 1633–1644.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., & Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46–54.

Article  PubMed  Google Scholar 

Ananthakrishnan, A. N.(2015). Epidemiology and risk factors for IBD. Nature Reviews Gastroenterology & Hepatology, 12(4), 205–217.

Article  Google Scholar 

Li, X., Ling, Y., Huang, X., Zhou, T., Wu, S., Zhang, S., Zhou, H., Kang, Y., Wang, L., Wang, X., & Yin, W. (2023). Rosa roxburghii tratt fruit extract prevents dss-induced ulcerative colitis in mice by modulating the gut microbiota and the IL-17 signaling pathway. Nutrients, 15(21), 4560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, X., He, X., Peng, C., He, Y., Wang, C., Tang, W., Chen, H., Feng, Y., Liu, D., Li, T., & He, L. (2022). Improvement of ulcerative colitis by aspartate via RIPK pathway modulation and gut microbiota composition in mice. Nutrients, 14(18), 3707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P., & Elson, C. O. (1994). Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology, 107(6), 1643–1652.

Article  CAS  PubMed  Google Scholar 

Huang, S., Fu, Y., Xu, B., Liu, C., Wang, Q., Luo, S., Nong, F., Wang, X., Chen, J., Zhou, L., & Luo, X. (2020). Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway. Phytomedicine, 68, 153179.

Article  CAS  PubMed  Google Scholar 

Katinios, G., Casado-Bedmar, M., Walter, S. A., Vicario, M., González-Castro, A. M., Bednarska, O., Söderholm, J. D., Hjortswang, H. & Keita, Å. V. (2020). Increased colonic epithelial permeability and mucosal eosinophilia in ulcerative colitis in remission compared with irritable bowel syndrome and health. Inflammatory Bowel Disease, 26(7), 974–984.

Article  Google Scholar 

Qiu, S., Li, P., Zhao, H. & Li, X. (2020). Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway. International Immunopharmacology, 78, 106018.

Article  CAS  PubMed  Google Scholar 

Nighot, P., Al-Sadi, R., Rawat, M., Guo, S., Watterson, D. M. & Ma, T. (2015). Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 309(12), 29.

Article  Google Scholar 

Jodeleit, H., Milchram, L., Soldo, R., Beikircher, G., Schönthaler, S., Al-Amodi, O., Wolf, E., Beigel, F., Weinhäusel, A., Siebeck, M., & Gropp, R. (2020). Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis. PLoS One, 15(2), e0228615.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaidi, D., Huynh, H. Q., Carroll, M. W., Baksh, S. & Wine, E. (2018). Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease. Clinical and Experimental Gastroenterology, 11, 217–231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J. & Cominelli, F. (1999). IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: expression and localization in intestinal mucosal cells. Journal of Immunology, 162(11), 6829–6835.

Article  CAS  Google Scholar 

Wędrychowicz, A., Tomasik, P., Zając, A. & Fyderek, K. (2018). Prognostic value of assessment of stool and serum IL-1β, IL-1ra and IL-6 concentrations in children with active and inactive ulcerative colitis. Archives of Medical Science, 1, 107–114.

Article